Treatment of Urinary Incontinence in Women With Spinal Cord Injury
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02427230 |
Recruitment Status :
Completed
First Posted : April 27, 2015
Last Update Posted : August 22, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Spinal Cord Injury Urinary Incontinence | Behavioral: Pelvic floor muscle training Drug: vaginal electrical stimulator (CefarPeristim Pro) | Not Applicable |
SCI patients often experience neurogenic bladder dysfunction with neurogenic detrusor overactivity or areflexic bladder. Due to this, 40-50 % of the SCI population suffers from urinary incontinence, which often reduces the patient's quality of life.
In order to manage the neurogenic bladder dysfunction, SCI patients use specialized bladder emptying methods, most frequently clean intermittent catheterization. To reduce the symptoms of neurogenic detrusor overactivity and urinary incontinence in patients with a SCI, medical anticholinergic therapy can be assessed, but the effect is sparse and many adverse effects have been reported. Injection of Botulinum-A toxin in the bladder has shown great potential in minimizing the symptoms of neurogenic detrusor overactivity and urinary incontinence, though it is an expensive and invasive method that needs to be repeated due to its temporary effect.
PFMT and NMES of the pelvic muscles are non-invasive and cheap treatments without side effects and several studies have demonstrated the positive effect of intravaginal NMES and/or PFMT on urinary incontinence in able-bodied women as well as women with neurological disorders like multiple sclerosis.
Despite the fact that NMES of weak or paralyzed striated muscles has been used for decades in patients suffering from SCI, to our knowledge, no study has previously investigated the effect of PFMT and intravaginal NMES in women with SCI.
The aim of this study is to evaluate the effect of PFMT and intravaginal NMES on Urinary Incontinence and Quality of Life in women with SCI. In particular, we will investigate the potential additional effect of intravaginal NMES, when NMES is conducted in combination with PFMT.
This study is designed as a randomized clinical trial, investigating the effect of PFMT alone and in combination with intravaginal NMES. We will include 40 female patients with an incomplete SCI and urinary incontinence. After physiotherapeutic guidance, the patients perform PFMT or PFMT + NMES daily at home for 12 weeks with follow-up evaluations every fourth week.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 27 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Treatment |
Official Title: | The Effect of Pelvic Floor Muscle Training and Neuromuscular Electrical Stimulation on Urinary Incontinence and Quality of Life in Women With Spinal Cord Injury |
Study Start Date : | May 2015 |
Actual Primary Completion Date : | March 2017 |
Actual Study Completion Date : | March 2017 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Pelvic floor muscle training (PFMT)
Pelvic floor muscle training daily during 12 weeks.
|
Behavioral: Pelvic floor muscle training
The intervention in group 1 consists of three private lessons in PFMT conducted by a physiotherapist every 4th week. At each consultation the physiotherapist will use manual palpation of the pelvic floor muscles and Electromyography Biofeedback (EMG). Patients will be instructed to carry out three series of approximately 10 near-maximal pelvic floor muscle contractions held for approximately 6-8 seconds daily during 12 weeks. Other Name: Group 1 |
Active Comparator: PFMT and electrical stimulation
Pelvic floor muscle training and intravaginal neuromuscular electrical stimulation daily during 12 weeks.
|
Behavioral: Pelvic floor muscle training
The intervention in group 2 consist of three private lessons in PFMT and intravaginal NMES conducted by a physiotherapist every 4th week. At each consultation the physiotherapist will use manual palpation of the pelvic floor muscles and Electromyography Biofeedback (EMG). Patients will be instructed to carry out three series of approximately 10 near-maximal pelvic floor muscle contractions held for approximately 6-8 seconds daily during 12 weeks. Additionally, patients will be instructed on how to use intravaginal NMES and each patient receives a vaginal electrical stimulator (CefarPeristim Pro). The NMES settings consist of two different frequencies, 40 Hz and 10 Hz, and patients are instructed to use both settings daily for maximum 30 minutes during 12 weeks. Other Name: Group 2 Drug: vaginal electrical stimulator (CefarPeristim Pro) electrical stimulation |
- International Consultation on Incontinence Questionnaire, Urinary Incontinence, Short Form (ICIQ-UI-SF) [ Time Frame: up to week 24 ]
- International Consultation on Incontinence Questionnaire, Overactive Bladder (ICIQ-AOB) [ Time Frame: up to week 24 ]
- Urethral Pressure Reflectometry (UPR) parameters [ Time Frame: up to week 24 ]UPR is a novel method of measuring the pressure and cross-sectional area in the female urethra
- 3 days voiding diary [ Time Frame: 3 days ]
- 24 hour pad test [ Time Frame: 24 hour ]
- International Spinal Cord Injury Quality of Life Basic Data Set [ Time Frame: up to week 24 ]
- Patient Global Index of Improvement scale (PGI-I) [ Time Frame: up to week 24 ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Incomplete SCI graded C, D og E on ASIA Impairment Scale, sustained minimum 3 months ago
- urinary incontinence, corresponding to a total ICIQ-UI-SF score ≥ 8
Exclusion Criteria:
- Regular treatment with botox bladder injections or < 1 year since last botox injection
- Lack of urodynamic investigation after the SCI
- Pregnancy
- Pacemaker
- Lack of ability to contract the pelvic floor muscles during objective clinical examination

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02427230
Denmark | |
Department of Gynaecology and Obstetrics, Herlev University Hospital | |
Herlev, Denmark, 2730 |
Principal Investigator: | Marlene Elmelund, MD | Clinic for Spinal Cord Injuries, Glostrup University Hospital/Rigshospitalet and Department of Gynaecology and Obstetrics, Herlev University Hospital | |
Study Director: | Fin Biering-Sørensen, MD DMSc Prof | Clinic for Spinal Cord Injuries, Glostrup University Hospital/Rigshospitalet | |
Study Director: | Niels Klarskov, MD Lecturer | Department of Gynaecology and Obstetrics, Herlev University Hospital |
Responsible Party: | Marlene Elmelund, MD, Glostrup University Hospital, Copenhagen |
ClinicalTrials.gov Identifier: | NCT02427230 |
Other Study ID Numbers: |
H-2-2014-113 20.941 ( Other Grant/Funding Number: Gross. L.F. Foghts Fond ) |
First Posted: | April 27, 2015 Key Record Dates |
Last Update Posted: | August 22, 2017 |
Last Verified: | August 2017 |
Pelvic Floor Muscle Training Neuromuscular Electrical Stimulation Urinary Incontinence Spinal Cord Injury |
Spinal Cord Injuries Urinary Incontinence Enuresis Wounds and Injuries Spinal Cord Diseases Central Nervous System Diseases Nervous System Diseases Trauma, Nervous System |
Urination Disorders Urologic Diseases Lower Urinary Tract Symptoms Urological Manifestations Behavioral Symptoms Elimination Disorders Mental Disorders |